Wikidata entity: Q408963
C₂₂H₂₅N₃O (P274)
Quantities
| P2067 | mass | 347.199762 |
| P233 | canonical SMILES | String | C1CN(CCC1NC(=O)C2=CC=CC=C2)CCC3=CNC4=CC=CC=C43 | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2175 | medical condition treated | ... | Q41861 (arterial hypertension) | arterial hypertension |
| P2175 | medical condition treated | ... | Q506659 (prostatic hypertrophy) | prostatic hypertrophy |
| P129 | physically interacts with | ... | Q4734884 (Adrenoceptor alpha 1A) | Adrenoceptor alpha 1A |
| P129 | physically interacts with | ... | Q4734886 (Adrenoceptor alpha 1B) | Adrenoceptor alpha 1B |
| P129 | physically interacts with | ... | Q4734887 (Adrenoceptor alpha 1D) | Adrenoceptor alpha 1D |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q575890 (antihypertensive drug) | antihypertensive drug |
| P2868 | subject has role | ... | Q50430371 (adrenergic alpha-1 receptor antagonists) | adrenergic alpha-1 receptor antagonists |
Why not click here or view trends?
log id: 2155604